AU2001280124A1 - Ibuprofen solutions for capsule-filling and capsule prepartions - Google Patents

Ibuprofen solutions for capsule-filling and capsule prepartions

Info

Publication number
AU2001280124A1
AU2001280124A1 AU2001280124A AU8012401A AU2001280124A1 AU 2001280124 A1 AU2001280124 A1 AU 2001280124A1 AU 2001280124 A AU2001280124 A AU 2001280124A AU 8012401 A AU8012401 A AU 8012401A AU 2001280124 A1 AU2001280124 A1 AU 2001280124A1
Authority
AU
Australia
Prior art keywords
capsule
ibuprofen
prepartions
filling
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280124A
Other languages
English (en)
Inventor
Toshio Inagi
Soichiro Kato
Yasuo Shinoda
Katsuyuki Tsumori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of AU2001280124A1 publication Critical patent/AU2001280124A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001280124A 2000-08-25 2001-08-23 Ibuprofen solutions for capsule-filling and capsule prepartions Abandoned AU2001280124A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-255827 2000-08-25
JP2000255827 2000-08-25
PCT/JP2001/007223 WO2002015900A1 (fr) 2000-08-25 2001-08-23 Solutions d'ibuprofene destinees a etre mises en gelules et preparations en gelules

Publications (1)

Publication Number Publication Date
AU2001280124A1 true AU2001280124A1 (en) 2002-03-04

Family

ID=18744550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280124A Abandoned AU2001280124A1 (en) 2000-08-25 2001-08-23 Ibuprofen solutions for capsule-filling and capsule prepartions

Country Status (14)

Country Link
US (1) US20030187070A1 (de)
EP (1) EP1321140B1 (de)
JP (1) JP3553562B2 (de)
KR (1) KR100762115B1 (de)
CN (1) CN1215837C (de)
AT (1) ATE292461T1 (de)
AU (1) AU2001280124A1 (de)
CA (1) CA2419147C (de)
DE (1) DE60109945T2 (de)
EA (1) EA005494B1 (de)
ES (1) ES2240492T3 (de)
PT (1) PT1321140E (de)
TW (1) TWI285115B (de)
WO (1) WO2002015900A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1701710A1 (de) * 2004-01-09 2006-09-20 Wyeth Mikroemulsionen für pharmazeutische zusammensetzungen
JP4710240B2 (ja) * 2004-03-31 2011-06-29 ゼリア新薬工業株式会社 医薬組成物
JP2005289905A (ja) * 2004-03-31 2005-10-20 Zeria Pharmaceut Co Ltd 医薬組成物
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
US20070224261A1 (en) * 2006-03-22 2007-09-27 Peter Draper Eutectic liquid drug formulation
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
RU2596989C2 (ru) 2010-04-15 2016-09-10 Крафт Фудс Груп Брэндс Ллс Соединения, композиции и способы для снижения или устранения горького вкуса
KR20140076629A (ko) 2011-10-20 2014-06-20 크로모셀 코포레이션 쓴맛을 감소시키거나 또는 제거하기 위한 화합물, 조성물 및 방법
EP3160590B1 (de) * 2014-06-30 2018-04-25 Mitochondrial Substrate Invention Limited Nährstofflösungen zur erhöhung der kognitiven funktion
WO2016084099A1 (en) * 2014-11-25 2016-06-02 Biological E Limited Soft gelatin capsule composition of anti-tussive agents
US20210353573A1 (en) 2018-10-08 2021-11-18 Chanelle Pharmaceuticals Manufacturing Ltd. A soft-gel capsule formulation, method of manufacture and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
DE69231359T2 (de) * 1991-05-13 2001-02-08 Boots Co Ltd Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
EP0695175A1 (de) * 1993-04-30 1996-02-07 The Procter & Gamble Company Überzogene pharmazeutische zusammensetzungen
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
JPH08333246A (ja) * 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
AU3444297A (en) * 1996-07-12 1998-02-09 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
US5914129A (en) * 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
ES2282134T3 (es) * 1999-09-11 2007-10-16 THE PROCTER & GAMBLE COMPANY Copolimeros de polioxialquileno que contienen vehiculos liquidos fluidos.

Also Published As

Publication number Publication date
EA200300292A1 (ru) 2003-10-30
DE60109945D1 (de) 2005-05-12
TWI285115B (en) 2007-08-11
CA2419147A1 (en) 2003-02-10
JPWO2002015900A1 (ja) 2004-06-10
CA2419147C (en) 2008-10-07
EA005494B1 (ru) 2005-02-24
CN1471389A (zh) 2004-01-28
EP1321140A4 (de) 2004-01-21
WO2002015900A1 (fr) 2002-02-28
EP1321140A1 (de) 2003-06-25
PT1321140E (pt) 2005-06-30
KR20030068535A (ko) 2003-08-21
EP1321140B1 (de) 2005-04-06
DE60109945T2 (de) 2006-04-27
CN1215837C (zh) 2005-08-24
ATE292461T1 (de) 2005-04-15
ES2240492T3 (es) 2005-10-16
JP3553562B2 (ja) 2004-08-11
KR100762115B1 (ko) 2007-10-04
US20030187070A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2001280124A1 (en) Ibuprofen solutions for capsule-filling and capsule prepartions
Brandt The role of analgesics in the management of osteoarthritis pain
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
WO2002067852A3 (en) A controlled release pharmaceutical composition
TNSN01123A1 (fr) Formes posologiques nouvelles a liberation controlee
DE69636413D1 (de) Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe
ES2247736T3 (es) Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica.
AU3913297A (en) Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
UA82979C2 (ru) Фармацевтическая композиция, пригодная для перорального введения, которая содержит no-высвобождающие нспвл, лекарственная форма, фармацевтическая комбинация и способы лечения
MX9801727A (es) Composicion farmaceutica para administracion oral.
DE69928815D1 (de) Dosierungsform mit flüssiger formulierung
DE69719189T2 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
PT1170003E (pt) Sistema de administracao de farmacos auto-emulsionante para
CA2169159A1 (en) Pharmaceutical composition containing a drug/.beta.-cyclodextrin complex in combination with an acid-base couple
IT1307852B1 (it) Un dispositivo per la somministrazione per via transcutanea dimolecole contenute in un prodotto veicolante relativamente viscoso,
ES2091014T3 (es) Composiciones de mezcla para bebidas que contienen psyllium.
DE69710423D1 (de) Orale pharmazeutische Zubereitung mit antipyretischer, analgetischer und entzündungshemmender Wirkung.
ES2051658T1 (es) Comprimido efervescente de facil administracion.
AR034436A1 (es) Agentes terapeuticos.
DE69729729D1 (de) Arzneimittel zur anwendung im mund
JPS5762220A (en) Embrocation for external use
ES2175086T3 (es) Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.
Maru et al. Formulation and evaluation of tenoxicam gels for tropical use
MC200017A1 (fr) Procede pour la preparation d'un medicament a base de Ranitidine Chlohydrate + vitamine C en solution liquide sous forme de comprime effervescent
CO4370015A1 (es) Formulacion farmaceutica comprendiendo amoxicilina y potasio de clavulanato